Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons
- 31 December 1998
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 116 (6) , 1043-1051
- https://doi.org/10.1016/s0022-5223(98)70057-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A baboon model for hematologic studies of cardiopulmonary bypassJournal of Laboratory and Clinical Medicine, 1997
- ENOXAPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN SUPPRESSES PROTHROMBIN ACTIVATION MORE EFFECTIVELY THAN UNFRACTIONATED HEPARIN IN PATIENTS TREATED FOR VENOUS THROMBOEMBOLISMThrombosis Research, 1997
- Cardiopulmonary bypass for heparin-induced thrombocytopenia: Management with a heparin-bonded circuit and enoxaparinThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathwayJournal of Immunological Methods, 1993
- Low molecular weight heparinBlood, 1992
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Neutralization of Enoxaparine-lnduced Bleeding by Protamine SulfateThrombosis and Haemostasis, 1990
- Development and Performance Characteristics of a Competitive Enzyme Immunoassay for Fibrinopeptide ASeminars in Thrombosis and Hemostasis, 1984
- Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassayBlood, 1979
- Platelet Function in HyperlipoproteinemiaNew England Journal of Medicine, 1974